These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 38962968)

  • 21. A systematic literature review on the global epidemiology of Dravet syndrome and Lennox-Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality.
    Sullivan J; Benítez A; Roth J; Andrews JS; Shah D; Butcher E; Jones A; Cross JH
    Epilepsia; 2024 May; 65(5):1240-1263. PubMed ID: 38252068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine.
    Dini G; Tulli E; Dell'Isola GB; Mencaroni E; Di Cara G; Striano P; Verrotti A
    Front Pharmacol; 2022; 13():832929. PubMed ID: 35668937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2022 Oct; 36(10):1079-1111. PubMed ID: 36194365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Wijnen B; Armstrong N; Ramaekers B; Witlox W; Westwood M; Fayter D; Ryder S; Buksnys T; Worthy G; Misso K; Grimm S; Kleijnen J; Joore M
    Pharmacoeconomics; 2020 Oct; 38(10):1043-1053. PubMed ID: 32514751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.
    Strzelczyk A; Pringsheim M; Mayer T; Polster T; Klotz KA; Muhle H; Alber M; Trollmann R; Spors H; Kluger G; Kurlemann G; Schubert-Bast S
    Epilepsia; 2021 Oct; 62(10):2518-2527. PubMed ID: 34378197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial.
    Knupp KG; Scheffer IE; Ceulemans B; Sullivan JE; Nickels KC; Lagae L; Guerrini R; Zuberi SM; Nabbout R; Riney K; Shore S; Agarwal A; Lock M; Farfel GM; Galer BS; Gammaitoni AR; Davis R; Gil-Nagel A
    JAMA Neurol; 2022 Jun; 79(6):554-564. PubMed ID: 35499850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
    Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
    Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome.
    Balagura G; Cacciatore M; Grasso EA; Striano P; Verrotti A
    CNS Drugs; 2020 Oct; 34(10):1001-1007. PubMed ID: 32875491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome.
    Lagae L; Schoonjans AS; Gammaitoni AR; Galer BS; Ceulemans B
    Epilepsia; 2018 Oct; 59(10):1881-1888. PubMed ID: 30146701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea.
    Koo CM; Kim SH; Lee JS; Park BJ; Lee HK; Kim HD; Kang HC
    J Korean Med Sci; 2020 Dec; 35(50):e427. PubMed ID: 33372424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-seizure medications for Lennox-Gastaut syndrome.
    Brigo F; Jones K; Eltze C; Matricardi S
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ; Chin RFM
    Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies.
    Martin P; Reeder T; Sourbron J; de Witte PAM; Gammaitoni AR; Galer BS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying the burden of disease in patients with Lennox Gastaut syndrome.
    Spoor JKH; Greco T; Kamp MA; Faini S; Senft C; Dibué M
    Epilepsy Behav Rep; 2021; 16():100508. PubMed ID: 34917922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.
    LoPresti M; Igarashi A; Sonohara Y; Bowditch S
    Epilepsy Behav; 2024 May; 154():109741. PubMed ID: 38555725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy.
    Samanta D
    Children (Basel); 2022 Aug; 9(8):. PubMed ID: 36010049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
    Gil-Nagel A; Falip M; Sánchez-Carpintero R; Abad-Sazatornil MR; Poveda JL; Aibar JÁ; Cardenal-Muñoz E; Aras LM; Sánchez R; Sancho-López A; Trillo-Mata JL; Torrejón M; Gil A
    Epilepsy Behav; 2022 Jul; 132():108711. PubMed ID: 35588562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenfluramine: a plethora of mechanisms?
    Sourbron J; Lagae L
    Front Pharmacol; 2023; 14():1192022. PubMed ID: 37251322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Lattanzi S; Trinka E; Russo E; Del Giovane C; Matricardi S; Meletti S; Striano P; Damavandi PT; Silvestrini M; Brigo F
    Drugs; 2023 Oct; 83(15):1409-1424. PubMed ID: 37695433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
    Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
    Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.